The Best Biotech Stock That Has Nothing to Do with Vaccines

The government's $9 billion push to develop COVID-19 vaccines may be dominating headlines this year. But that doesn't mean the private sector has stopped pouring money into solving every other health problem under the sun. While investors have sought after vaccine stocks hoping for a big pop, that same pop can come from smaller companies who can solve other problems. Today, I want to show you one small company that's solving a problem for one in eight couples. A problem more prevalent than diabetes, asthma, and depression, and only outpaced by arthritis and chronic kidney disease, which make up over a $100 billion market. Read more... Tags: tech stocks To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2020 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post The Best Biotech Stock That Has Nothing to Do with Vaccines appeared first on Money Morning - We Make Investing Profitable .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.